Language selection

Search

Patent 2686065 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2686065
(54) English Title: EQUILIBRIUM NON-CONSUMING FLUORESCENCE SENSOR FOR REAL TIME INTRAVASCULAR GLUCOSE MEASUREMENT
(54) French Title: CAPTEUR DE FLUORESCENCE D'EQUILIBRE DE NON CONSOMMATION PERMETTANT DE MESURER LE TAUX DE GLUCOSE INTRAVASCULAIRE EN TEMPS REEL
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 5/00 (2006.01)
(72) Inventors :
  • MARKLE, DAVID R. (United States of America)
  • MARKLE, WILLIAM (United States of America)
(73) Owners :
  • GLUMETRICS, INC. (United States of America)
(71) Applicants :
  • GLUMETRICS, INC. (United States of America)
(74) Agent: MCMILLAN LLP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2008-05-09
(87) Open to Public Inspection: 2008-11-20
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2008/063330
(87) International Publication Number: WO2008/141241
(85) National Entry: 2009-11-02

(30) Application Priority Data:
Application No. Country/Territory Date
60/917,307 United States of America 2007-05-10

Abstracts

English Abstract

Embodiments of the present invention relates to analyte sensors 13. In particular, the preferred embodiments of the present invention relate to non-consuming intravascular glucose sensors 13 based on fluorescence chemistry.


French Abstract

Certains modes de réalisation de cette invention concernent des capteurs d'analytes (13). Les modes de réalisation préférés de cette invention concernent, plus particulièrment, des capteurs de glucose intravasculaire (13) de non consommation basé sur la chimie de fluorescence.

Claims

Note: Claims are shown in the official language in which they were submitted.




WHAT IS CLAIMED IS:


1. An intravascular sensor for determining an analyte concentration in blood
comprising:

an optical fiber comprising a sensor chemistry portion capable of insertion
into
a blood vessel, the sensor chemistry portion comprising:

an analyte binding molecule capable of binding an analyte; and

a fluorophore associated with the analyte binding molecule, the
fluorophore having a first fluorescence when the analyte binding molecule is
not bound to the analyte and a second fluorescence when the analyte binding
molecule is bound to the analyte;
a light source; and
a detector.


2. The sensor of Claim 1, wherein the first fluorescence is a first
fluorescence
intensity and the second fluorescence is a second fluorescence intensity.


3. The sensor of Claim 1, wherein the first fluorescence is a first
fluorescence
lifetime and the second fluorescence is a second fluorescence lifetime.


4. The sensor of Claim 1, wherein the analyte is glucose.


5. The sensor of Claim 1, further comprising an optical fiber.

6. The sensor of Claim 1, wherein the light source is a laser.


7. The sensor of Claim 1, wherein the light source is a light emitting diode.

8. The sensor of Claim 1, wherein the sensor chemistry portion further
comprises
a hydrogel that substantially immobilizes the analyte binding molecule and the
fluorophore
and is permeable to the analyte.


9. The sensor of Claim 1, wherein the sensor chemistry portion further
comprises
a membrane wlierein the analyte binding molecule and the fluorophore are
substantially
retained within a volume at least partially enclosed by the membrane.


10. An intravascular sensor for determining an analyte concentration in blood
comprising:

a sensor chemistry portion capable of insertion into a blood vessel, the
sensor
chemistry portion comprising:


-46-



an analyte binding molecule capable of binding an analyte; and

a fluorophore associated with the analyte binding molecule, the
fluorophore having a first fluorescence intensity when the analyte binding
molecule is not bound to the analyte and a second fluorescence intensity when
the analyte binding molecule is bound to the analyte;
a light source; and
a detector.


11. An intravascular sensor for determining an analyte concentration in blood
comprising:

a sensor chemistry portion capable of insertion into a blood vessel, the
sensor
chemistry portion comprising:

an analyte binding molecule capable of binding an analyte; and

a fluorophore associated with the analyte binding molecule, the
fluorophore having a first fluorescence lifetime when the analyte binding
molecule is not bound to the analyte and a second fluorescence lifetime when
the analyte binding molecule is bound to the analyte;
a light source; and
a detector.


12. A method for determining the glucose concentration in blood comprising:
providing the sensor of any of Claims 1-11;
inserting the sensor into a blood vessel;

irradiating the fluorophore with an excitation signal;
detecting a fluorescence emission from the fluorophore; and
determining the concentration of glucose.


13. The method of Claim 12, wherein the excitation signal is a pulse of light.

14. The method of Claim 13, further comprising measuring the decay of the
fluorescence emission over time; and

calculating a fluorescence lifetime.


15. The method of Claim 12, wherein the excitation signal is frequency
modulated.


-47-



16. The method of Claim 15, further comprising measuring the phase shift
between the fluorescence emission and the excitation signal.


17. The method of Claim 16, further comprising calculating a fluorescence
lifetime.


18. The method of Claim 15, further comprising measuring a modulation ratio;
and

calculating a fluorescence lifetime.


19. The method of Claim 12, further comprising measuring the fluorescence
intensity of the fluorescence emission.


20. An intravascular sensor for determining an analyte concentration in blood,

comprising an optical fiber comprising a sensor chemistry portion disposed
along a distal
region of the optical fiber, wherein the sensor chemistry portion is sized and
physiologically
compatible with residing in a blood vessel, wherein the sensor chemistry
portion is selected
from equilibrium fluorescence chemistry or lifetime chemistry.


-48-

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
EQUILIBRIUM NON-CONSUMING FLUORESCENCE SENSOR FOR REAL TIME
IN TRAVASCULAR GLU COSE MEASUREMENT
CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the priority benefit to U.S. Provisional No.
60/917,307 filed May 10, 2007, the entirety of whicb is hereby incorporated by
reference
herein.

BACKGROUND OF THE INVENTION
Field of the Invention

[0002] Embodiments of the present invention relates to analyte sensors. In
particular, the preferred embodiments of the present invention relate to non-
consuming
intravascular glucose sensors based on fluorescence cbcrnistry.

Description of the Rel atedArt

[0003] There has been an on-going effort over many years to use fluorescence
techniques to rneasure polyhydroxyl compound (e.g., glucose) concentration in
bodily fluids.
But despite the effort. no practical system has been developed and
commercialized for in vivo
monitoring. Several attempts have been made to detect glucose by fluorescence
using dyes
associated with boronic acid groups. Boronate moicties bind glucose
reversibly. When
boronic acid functionalized fluorescent dyes bind glucose, the properties of
the dye are
affected, such that a signal related to the concentration of glucose may be
generated and
detected. These changes have been used in the past to measure glucose
concentration.

[0004] Russell (ll_S. Pat. Nos. 5,137,833 and 5,512,246) used a boronic acid
functionalized dye that bound glucose and generated a signal related to the
glucose
concentration. James et al. (U.S. Pat. No. 5,503,770) employed a similar
principle, but
combined a fluorescent dye, an amine quenching functionaliÃy, and boronic acid
in a single
complex. The fluorescence emission from the complex varied with the amount of
glucose
binding. Van Antwerp et al. (U.S. Pat. Nos. 6,002,954 and 6,011,984) combined
features of
the previously cited references and also disclosed a device purported to be
irnplantable. A. E.
-1-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
Colvin, Jr. (U.S. Pat. No. 6.304,766) also disclosed optical-based sensing
devices for in situ
sensing in humans that utilize boronate-functionalized dyes.

100051 Certain measurable parameters using blood or bodily fluid, such as pH
and
concentrations of 02, CO,. Na+. W. and polyhydroxyl compounds. like glucose,
have been
determined in vivo. The ability to do these measurements in vivo is important
because it is
necessary to make frecluent determinations of such analytes wlien monitoring a
patient.
Typically, one sensor for each analyte has been placed in a patient's blood
vessel(s). If it is
desired to measure several analytes, a plurality of sensors is often required,
which can cause
attendant discomfort to the patient and complexity of the electronic
monitoring equipment.

[0006] In an effort to solve the design problenls posed by the limitation in
physical dimension for in vivo inonitoring, others have incorporated different
dyes into one
device to get simultaneous readings of two parameters. For example, Alder et
al. (U.S. Pat.
No. 5,922,612) disclosed a method for optical determination of pH and ionic
strength of an
aqueous sample using two different dyes on one sensor. Gray et al. (U.S. Pat.
No. 5,176,882)
taught the use of a fiber optic device incorporating a hydrophilic polymer
with immobilized
pH sensitive dye and potassium or calcium sensitive fluorescent dyes to
measure the analyte
concentration in conjunction with pH. In U.S. Pat. No. 4,785,814, Kane also
disclosed the
use of two dyes embedded in a composite membrane for the simultaneous
measurements of
pH and oxygen content in blood. However, incorporation of multiple dyes into a
single
sensor complicates the manufacture of such sensors.

100071 Besides the foregoing problems associated with separate indwelling
sensors for each analyte being monitored, particularly in the intensive care
setting, and
multiple dye sensors, another problem associated with many dye-based analyte
sensors is pH
sensitivity. A slight change in pH may modify or attenuate fluorescence
emissions, and cause
inaccurate readings. This problem is particularly acute for monitoring blood
glucose levels in
diabetic patients, whose blood pH may fluctuate rapidly. Since accurate blood
glucose level
measurements are essential for treating these patients, there is a significant
need for a glucose
sensor that facilitates real-time correction of the pH effect without
requiring separate
indwelling pH and analyte sensors, or sensors having multiple dyes.

-2-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
100081 Ratiometric pH deteraxaination using fluorescent dye(s) is known. Given
a
fluorophore that has an acid and base form, the ratio of the emission
intensity of the two
forms can be used as a m.easure of the pH that is insensitive to fluorophore
concentration .
See e.g., U.S. Patent Publication No. 2005/0090014 which describes an HPTS-
derived pH
sensitive dye (incorporated herein in its entirety by reference); Niu C.G. et
al. 2005 Anal.
Biaanal. Chein. 383(2):349-357, which describes a pH-sensitive dye meso-
5,10,15,20-tetra-
(4-allyloxyphenyl)porphyrin (TAPP) as an indicator, and a pH-insensitive
benzothioxanthene
derivative as a reference, for fluorescence ra.tiometric measurement; Turner
N.G. et al. 1998
J. Investig. Derrnatol. Symp. Proc. Aug 3(2):110-3, which discloses dual-
emission
ratiometric imaging using the fluorophore, carboxy seminaphthorhodafluor-1,
which displays
a pH-dependent shift in its emission spectrum; and Badugu R. et a]. 2005
Talanta 66:569-
574, which describes the use of 6-aminoquinolinium boronic acid dyes that show
spectral
shifts and intensity changes with pH in a wavelength-ratiometric manner.

100091 However, despite the inventor's recognition of a substantial urimet
need
for a sensor adapted to provide continuous intravascular monitoring of pH and
glucose,
wherein the glucose measurement may be corrected for pH effects, no one has
disclosed or
even suggested using a sensor comprising a single fluorophore that exhibits
properties
suitable to make a ratiometric pH measurement that is independent of the
fluorophore
concentration, where the same fluorophore is functionalized to bind glucose
and generate a
signal the intensity of which is related to the glucose concentration_

SUMMARY OF THE INVENTION

100101 An intravascular sensor is disclosed in accordance with preferred
embodiments of the present invention for determining the analyte concentration
in blood.
The sensor comprises an analyte binding molecule, wherein the analyte binding
molecule is
associated with a fluorophore; an analyte analog, wherein the analyte analog
is associated
with an acceptor, wherein the fluorophore is capable of einitting radiation at
a wavelength
that is absorbed at least in part by the acceptor, wherein the fluorophore is
capable of
transferring energy to the acceptor via fluorescence resonance energy transfer
when the
fluorophore is in close proximity to the acceptor; a light source; and a
detector.

-3-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
[0011] In some embodiments, the sensor further comprises a hydrogel, wherein
the analyte binding molecule and the analyte analog are substantially
immobilized in the
hydrogel, wherein the hydrogel is permeable to the analyte.

100I21 In some embodiments, the light source is a laser.

[0013] In some embodiments, the laser is capable of delivering a frequency
modulated excitation signal.

[00141 In some embodiments, the laser is capable of delivery a pulse of light.
100151 In some embodiments, the sensor further comprises an optical fiber.
[0016] In some embodiments, the analyte is glucose.

[0017] A method is disclosed in accordance with preferred embodiments of the
present invention for determining the glucose concentration in blood. The
method comprises
providing the sensor as described above; inserting the sensor into a blood
vessel; irradiating
the fluorophore with an excitation signal; detecting a fluorescence emission
from the
fluorophore; and determining the concentration of glucose.

[0018] In some embodiments, the excitation signal is a pulse of light.

100191 In some embodiments, the method further comprises measuring the decay
of the fluorescence emission over time and calculating a fluorescence
lifetime.

[00201 In some embodiments, the excitation signal is frequency modulated.

100211 In some embodirnents, the method further comprises measuring the phase
shift between the emission and the excitation signal.

100221 In some embodiments, the method further comprises calculating a
fluorescence lifetime.

100231 In some embodiments, the method further comprises measuring a
modulation ratio and calculating a fluorescence lifetime.

[00241 In one preferred embodiment, an intravascular sensor is disclosed for
determining an analyte concentration in blood. The sensor comprises an optical
fiber
comprising a sensor chemistry portion disposed along a distal region of the
optical fiber,
wherein the sensor chemistry portion is sized and physiologically compatible
with residing in
a blood vessel, wherein the sensor chemistry portion is selected from
equilibrium
fluoresceDce chemistry or lifetime chemistry.

-4-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
BRIEF DESCRIPTION OF THE DRAWINGS

100251 FIG. I is a flow chart showing the sensing mechanism of one embodiment
of the present inventian.

100261 FIG_ 2 shows a glucose and pH sensor and optical systein comprising two
excitation light sources and two detectors in accordance with one prefen-ed
ernbodirnent of
the present invention.

100271 FIG. 3 shows the absorption spectra ofHPTS at different pHs.

100281 FIG. 4 shows independence of ratiometric pH sensing using
HPTS/MABP4 using the Ir~QSejll~,soj ratio from glucose concentration_ The data
are plotted as
a ratio of the fluorescence emission for corresponding to excitation at 454
iirn (base) and 422
nm (isobestic point) vs. pH in various glucose concentrations.

100291 FIG. 5 shows glucose response curves for HPTS/MABP4 excited at 422
rnm (isobestic point) at different pHs.

100301 FIG. 6 shows the absorption spectra of SNARF-I at different pHs in
solution.

[0031] FIG. 7 shows glucose response curves for SNARF-1/3,3'-oBBV in
solution at different pHs excited at 514 nm/emission at 587 nm.

100321 FIG. 8 shows glucose response curves for SNARF-1/3,3'-oBBV in
solution at different pHs excited at 514 nm/emission at 625 nin.

100331 FIG. 9 shows ratiomet.ric sensing of pH at different glucose
concentrations
with SNARF- l/3,3'-oBBV in solution using the I(6as,)1I(,,d) ratio.

10034] FIG. 10 shows glucose response curves for HPTS-triLysMA/3,3'-
oBBV/DMAA at different pHs.

100351 FIG. II shows ratiometric sensing of pH at different glucose
concentrations using HPTS-triLysMAl3,3-oBBV/DMAA, using the l(haSP/i(,,d)
ratio.

100361 FIG. 12 shows ratiometric sensing of pH at different glucose
concentrations using HPTS-triCysMA/3,3'-oBBV/DMMA wherein the indicator system
is
immobilized on the end of an optical fiber, using the I(bQSe)/I(ac,d) ratio.

-5-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
100371 FIG. 13 shows a graph of the decay of fluorescence intensity over time
after a fluorophore is subjected to a pulse of excitation light.

100381 FIG. 14 shows a graph of the emission signal resulting from a frequency
modulated excitation signal.

100391 FIGS. 15A-C show the interaction between a glucose binding molecule
linked to a fluorophore, a glucose analog linked to an acceptor and a glucose
molecule.

-6-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

100401 In a preferred embodiment, the present invention is directed to an
optical
sensor capable of ineasuring two analytes with a single indicalor system. More
particularly,
the preferred sensor employs a single fluorophore (e_g., a fluorescent dye)
to: (l) determine
the concentration of a first analyte, e.g., H-' (pH), by a ratiometric method,
wherein such
determination is independent of the concentration of the fluorophore; and (2)
determine the
concentration of a second analyte, e.g., a polyhydroxyl compounds (e.g.,
preferably glucose)
by measuring the apparent fluorophore concentration (e.g., emission intensity
of the
fluorophore upon excitation), wherein the apparent fluorophore concentration
is dependent
on the concentration of the second a.nalyte. Further, where measurement of the
second
analyte concentration is dependent on the first analyte concentration (e.g.,
in optical systems
in which glucose measurement varies with pH-a common problem in this field),
then in
accordance with a preferred embodiment of the present invention, the measured
second
analyte concentration may be corrected for the contribution of the first
analyte coiicentration.
The sensor is preferably stable in aqueous media (e.g., physiological media,
blood, interstitial
fluid, etc.), and more preferably, the sensor is configured to be inserted
into a blood vessel
where it can remain indwelling for a period of time. Thus, in accordance with
a preferred
embodiment of the present invention, an optical sensor configured for
intravascular
placement is disclosed, which sensor is capable of measuring two analytes
(preferably pH and
glucose) with a single indicator system and correcting the glucose measurement
for any
contributions of pH.

100411 Although preferred embodiments of the sensor are directed intei= alia
to
ratiometric pH sensing, other first analyte concentrations rnay be detenruned
in accordance
with the broader scope of the present invention, as long as the indicator
system comprises a
fluorophore that exists in at least two forms the concentration of which are
associated with
the concentration of the frst analyte and the emission ratio of which is
independent of the
fluorophore concentration. Likewise, although glucose is used as a second
analyte example
herein, it is understood that the concentration of other polybydroxyl-
containing organic
compounds (carbohydrates, 1,2-diols, 1,3-diols and the like) in a solution may
be determined
using embodiments of this invention, as long as the indicator system comprises
a fluorophore
-7-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
that is operably coupled to a binding moiety that binds the second analyte,
wherein the signal
intensity of the fluorophore varies with the concentration of second analyte.
In some
embodiments, the concentration of second analytes may including non-
carbohydrates.

Indicator System

10042] The indicator systems used in accordance with preferred embodiments of
the present invention cornprise a fluorophore operably coupled to an analyte
binding moiety,
wherein analyte binding causes an apparent optical change in the fluorophore
concentration
(e.g., emission intensity). It is further desired that the fluorophore has
different acid and base
forms that exhibit a detectable difference in spectral properties such that
ratiometric pH
sensing may be enabled. For example, a glucose binding moiety such as 3,3'-
oBBV
(described in detail below) that is operably coupled to a fluorescent dye such
as HPTS-
triLysMA (described in detail below) will quench the emission intensity of the
fluorescent
dye, wherein the extent of quenching is reduced upon glucose binding resulting
in an increase
in emission intensity related to glucose concentration. In preferred
embodiments, the
indicator systems comprise a dye having at least two anionic groups and a
quencher having at
least two boronic acids. In further preferred embodiments, the indicator
systems also
comprise a nieans for immobilizing the sensing moieties (e.g., dye-quencher)
such that they
remain physically close enough to one another to react (quenching). Where in
vivo sensing is
desired, such immobilizing means are preferably insoluble in an aqueous
environment (e.g.,
intravascular), permeable to the target analytes, and iinpermeable to the
sensing moieties.
Typically, the immobilizing means comprises a water-insoluble organic polymer
matrix. For
example, the HPTS-triLysMA dye and 3,3'-oBBV quencher may be effectively
immobilized
within a DMAA (N,N-dimethylacrylamide) hydrogel matrix (described in detail
below),
which allows pH and glucose sensing in vivo.

[00431 Some exemplary and preferred fluorophores, analyte binding moieties and
immobilizing means are set forth in greater detail below.

Fluorophores
[0044] "Fluorophore" refers to a substance that when illuminated by light at a
particular wavelength emits light at a longer wavelength; i.e_ it fluoresces.
Fluorophores
include but are not limited to organic dyes, organometallic compounds, metal
chelates,
-8-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
fluorescent conjugated polymers, quantum dots or nanoparticles and
combinations of the
above. Fluorophores may be discrete moieties or substituents attached to a
polymer.

100451 Fluorophores that may be used in preferred embodiments are capable of
being excited by light of wavelength at or greater than about 400 nm, with a
Stokes shifl large
enough that the excitation and emission waveleilgths are separable by at least
10 nm. In
some embodiments, the separation between the excitation and emission
wavelengths may be
equal to or greater than about 30 nm. These fluorophores are preferably
susceptible to
quenehing by electron acceptor molecules, such as viologens, and are resistant
to photo-
bleaching. They are also preferably stable against photo-oxidation, hydrolysis
and
biodegradation_

1004fi] In some embodiments, the #luorophore may be a discrete compound.
100471 In some embodiments, the fluorophore may be a pendant group or a chain
unit in a water-soluble or water-dispersible polymer having molecular weight
of about 10,000
daltons or greater, forrning a dye-polymer unit. In one embodiment, such dye-
polymer unit
may also be non-covalently associated with a water-insoluble polymer matrix M'
and is
physically immobilized within the polymer matrix M', wherein M' is permeable
to or in
contact with analyte solution. In another embodiment, the dye on the dye-
polymer unit may
be negatively charged, and the dye-polymer unit may be immobilized as a
complex with a
cationic water-soluble polyiner, wherein said complex is permeable to or in
contact with the
analyte solution. In one embodiment, the dye may be one of the polymeric
derivatives of
hydroxypyrene trisulfonic acid. The polymeric dyes may be water-soluble, water-
swellable
or dispersible in water. In soine embodiments, the polymeric dyes may also be
cross-linked.
In preferred embodiments, the dye has a negative charge.

100481 In other embodiments, the dye molecule may be covalently bonded to the
water-insoluble polymer matrix M', wherein said M' is permeable to or in
contact with the
analyte solution_ The dye molecule bonded to M' may form a structure M'-L'-
Dye. L' is a
hydrolytically stable covalent linker that covalently connects the sensing
moiety to the
polymer or matrix. Examples of L' include lower alkylene (e.g., Cl-C$
alkylene), optionally
terninated with or interrupted by one or more divalent connecting groups
selected from
sulfonamide (--SO2NI1--), amide --(C=O)N--, ester --(C=O)--0--, ether.--O--,
sulfide --S--,
-9-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
sulfone (--SO2--), phenylene --CbH4--, urethane --NH(C=O)--O--, urea --
NH(C=O)NH--,
thiourea --NH(C=S)--NH--, amide --(C=O)NH--, amine --NR-- (where R is defined
as alkyl
having I to 6 carbon atoms) and the like, or a combination thereof In one
embodiment, the
dye is bonded to a polymer matrix through the sulfonamide functional groups.

[0049] In some embodiments, useful dyes include pyranine der~r vatives (e.g.
hydroxypyrene trisulfonamide derivatives and the like), which have the
following formula:

0
u
R'-S OH
11
0
~ \ 4
O 0
II
R2--S 5-R3
II
O o

wherein R~, R2, R3 are each -NHR4. R4 is -CH2CH2(-OCH,CH2-),X}; wherein X' is -
OH, -
OCH3COOH, -CONH2, -SO3H, -NH7, or OMe; and n is between about 70 and 10,000.
In
one emboditnent, the dyes may be bonded to a polymer through the sulfonamide
functional
groups. In other embodiments, the dye may be one of the polymeric derivatives
of
hydroxypyrene trisulfonic acid.

100501 In some embodiments, the fluorescent dye may be 8-hydroxypyrene-1,3,6-
trisulfonate (HPTS). The counterions can be H{ or a3iy other cation. HPTS
exhibits two
excitation wavelengths at around 450 nm and around 405 nrn, which correspond
to the
absorption wavelengths of the acid and its conjugate base_ The shift in
excitation wavelength
is due to the pH-dependent ionization of the hydroxyl group on HPTS. As the pH
increases,
HPTS shows an increase in absorbance at about 450 nm, and a decrease in
absorbance below
about 420 nm. The pH-dependent shift in the absorption maximum enables dual-
excitation
ratiometric detection in the physiological range. This dye has a molecular
weight of less than
500 daltons, so it will not stay within the polymer matrix, but it can be used
with an anion
exclusion membrane.

-10-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
Na' pss ~ QH

Na'C35 / 503 ha'

(the Na{ salt of HPTS-"pyranine")

100511 In another embodiment, the fluorescent dye may be polymers of 8-acetoxy-

pyrene-1,3,6-N, N',N"-tris-(methacryIpropylamidosulfonarr)ide) (acetoxy-HPTS-
MA):

0
H II
N-s ay
HN-/ 0

~O I /
0 0
HN-S 51-NH
o lo ~ _~
~-~ NH
O O~\~--!!//\

[0052] It is noted that dyes such as acetoxy-HPTS-MA (above) having no anionic
groups, may not give very strong glucose response when operably coupled to a
viologen
quencher, particularly a viologen quencher having only a single boronic acid
moiety.

[0053] In another embodiment, the fluorescent dye may be 8-hydroxy-pyrene-
1,3,6-N, N',N"-tris-(carboxypropylsulfonamide) (HPTS-C02):

0
H li
N-5 OH
O~/ IO
HO/ E I /
OE ! O
HN-5 $ NH
Ip O \_ _

HO OH

[0054] In another embodiment, the fluorescent dye may be 8-hydroxy-pyrene-
1,3,6-N, N',N"-tris-(methoxypolyethoxyethyl (-125) sulfonamide) (HPTS-PEG):

-11-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
0
H II
~N-S Y OH
O 10 r~

~O n I I

o~ ~ H hl
HN--S S-NH
~~ lo l0 7
o
0
oMe ONie

100551 It is noted that dyes such as HPTS-PEG (above) having no anionic
groups,
may not provide a very strong glucose response when operably coupled to a
viologen
quencher, particularly a viologen quencher having only a single boronic acid
moiety.

100561 Representative dyes as discrete compounds are the tris adducts formed
by
reacting 8-acetoxypyrene-1,3,6-trisulfonylchloride (HPTS-Cl) with an amino
acid, sucb as
amino butyric acid. Hydroxypyrene trisulfonamide dyes bonded to a polymer and
bearing
one or more anionic groups are most preferred, such as copolymers of 8-
hydroxypyrene-I -N-
(methaerylamidopropylsulfonamido)-N',N"-3,6-bis(carboxypropylsulfonamide) HPTS-
C02-
MA with HEMA, PEGMA, and the like.

100571 In another embodiment, the fluorescent dye may be HPTS-TriCys-MA:
6Nhli~S
H H~ 0
t~-S Dti
0
~
Bu4N03~ SC)3NBt,4
t'1-5 ~-N IN
~ H 0 11 i~ H
0 0 0
100581 This dye may be used with a quencher comprising boronic acid, such as
3,3'-oBBV.

100591 Of course, in some embodiments, substitutions otlier than Cys-MA on the
HPTS core are consistent with aspects of the present invention, as long as the
substitutions
are negatively charged and have a polymerizable group. Either L or D
stereoisomers of
-12-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
cysteine may be used. In some embodiments, only one or two of the sulfonic
acids may be
substituted. Likewise, in variations to I-NPTS-CysMA sliown above, otber
counterions
besides NBu4+ may be used, including positively charged metals, e.g., Na{. In
other
variations, the sulfonic acid groups may be replaced with e.g., phosphoric,
carboxylic, etc.
functional groups.

10060] Another suitable dye is HPTS-LysMA, which is pictured below as follows:
PJH

0
rda0g

j ~
rdaE?~C Ct?'Na
a
fH HPT-S-Ly.61A
HT+I--~

10061] Other examples include soluble copolymers of 8-acetoxypyrene-1,3,6-N,
N', N"-tris(methacrylamidopropylsulfonamide) with HEMA, PEGMA, or other
hydrophilic
comonomers. The phenolic substituent in the dye is protected during
polymerization by a
blocking group that can be removed by hydrolysis after completion of
polymerization. Such
suitable blocking groups, as for example, acetoxy, trifluoroacetoxy, and the
like, are well
known in the art-

10062] Fluorescent dyes, including HPTS and its derivatives are known and many
have been used in analyte detection. See e.g., U.S. Pat. Nos. 6,653,I41,
6,627,177,
5,512,246, 5,137,833, 6,800,451, 6,794,195, 6,804,544, 6,002,954, 6,319,540,
6,766,183,
5,503,770, and 5,763,238; and co-pending U.S. Patent Application Nos.
11/296,898 and
60/833,081; each of which is incorporated herein in its entirety by reference
thereto.

[0063] The SNARF and SNAFL dyes from Molecular Probes may also be useful
fluorophores in accordance with aspects of the present invention. The
structures of SNARF-
I and SNAFL-l are shown below.

-13-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
O O
~
N O, ~ HO O

OH OH
i I O O
HO~ HO'~
O O
SNARF-1 SNAFL-1

[0064] Additionally, a set of isomeric water-soluble f3uorescent probes based
on
both the 6-aminoyuinolinium and boronic acid moieties which show spectral
shifts and
intensity changes with pH, in a wavelength-ratiometric and colorimetric
rnariner may be
useful in accordance with some embodiments of the present invention (See e.g.,
Badugu, R.
et al. 2005 Talanta 65 (3):762-768; and Badugu, R. et al. 2005 Bioorg. Med.
Chem. 13
(1):113-119); incorporated herein in its entirety by reference.

[0065] Another example of a fluorescence dye that may be pH and saccharide
sensitive is tetrakis(4-sulfophenyl)porphine (TSPP)-shown below. TSPP may not
work
optimally in blood, where the porphyrin ring may react with certain metal
ions, like ferric,
and become non-fluorescent.
503
NH
O3~;_ N
HN
30j

(TSPP)
100661 Additional examples of pH sensitive fluorescent indicators that may be
useful for simultaneous determination of pH and glucose in the sensor of the
present

-14-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
invention are described in US 2005/0233465 and US 2005/0090014; each of which
is
incorporated herein by reference in its entirety.
Analyte Binding Moieties-Quenchers
10067] In accordance with broad aspects of the present invention, the analyte
binding moiety provides the at least dual functionality of being able to bind
analyte and being
able to modulate the apparent concentration of the fluorophore (e.g., detected
as a change in
emission signal intensity) in a manner related to the amount of analyte
binding. In preferred
embodiments, the analyte binding moiety is associated with a quencher.
"Quencher' refers to
a compound that reduces the emission of a fluorophore when in its presence.
Quencher (Q) is
selected from a discrete compound, a reactive intermediate which is
convertible to a second
discrete compound or to a polymerizable compound or Q is a pendant group or
chain unit in a
polymer prepared from said reactive intermediate or polyi-nerizable compound,
which
polyrner is water-soluble or dispersible or is an insoluble polymer, said
polymer is optionally
crosslinked.
[0068] In one example, the moiety that provides glucose recognition in the
embodiments is an aromatic boronic acid. The boronic acid is covalently bonded
to a
conjugated nitrogen-containing heterocyclic aromatic bis-onium structure
(e.g., a viologen).
"Viologen" refers generally to compounds having the basic stnicture of a
nitrogen containing
conjugated N-substituted heterocyclic ai-omatic bis-onium salt, such as 2,2'-,
3,3'- or 4,4'-N,N'
bis-(benzyl) bipyridium dihalide (i.e., dichloride, bromide chloride), etc.
Viologen also
includes the substituted phenanthroline compounds. The boronic acid
substituted quencher
preferably has a pKa of between about 4 and 9, and reacts reversibly with
glucose in aqueous
media at a pH from about 6.8 to 7_8 to form boronate esters. The extent of
reaction is related
to glucose concentration in the medium. pormation of a boronate ester
diminisbes quenehing
of the fluorphore by the viologen resulting in an increase in fluorescence
dependent on
glucose concentration. A useful bis-oniurn salt is compatible with the analyte
solution and
capable of producing a detectable change in the fluorescent emission of the
dye in the
presence of the analyte to be detected.
100691 Bis-onium salts in the embodiments of this invention are prepared from
conjugated heterocyclic aromatic di-nitrogen compounds. The conjugated
heterocyclic
-15-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
aromatic di-nitrogen compounds are selected from dipyridyls, dipyridyl
ethylenes, dipyridyl
phenylenes. phenanthrolines, and diazafluorenes, wherein the nitrogen atoms
are in a
different aromatic ring and are able to form an onium salt. It is understood
that all isomers of
said conjugated heterocyclic aromatic di-nitrogen compounds in which both
nitrogens can be
substituted are useful in this invention. In one embodiment, the quencher may
be one of the
bis-oniurn salts derived from 3,3'-dipyridyl, 4,4'-dipyridyl and 4,7-
phenanthroline.

100701 In some embodiments, the viologen-boronic acid adduct may be a discrete
compound having a molecular weight of about 400 daltons or greater. In other
embodiments,
it may also be a pendant group or a chain unit of a water-soluble or water-
dispersible polymer
with a molecular weight greater than about 10,000 daltons. In one embodiment,
the
quencher-polymer unit may be non-covalently associated with a polymer matrix
and is
physically immobilized therein. In yet anotber embodiment, the quencher-
polymer unit may
be immobilized as a complex witli a negatively charge water-soluble polymer.

100711 In other embodiments, the viologen-boronic acid moiety may be a pendant
group or a chain unit in a crosslinked, hydrophilic polymer or hydrogel
sufficiently penneable
to the analyte (e.g., glucose) to allow equilibrium to be established.

100721 In other embodiments, the quencher may be covalently bonded to a second
water-insoluble polymer matrix M2, which can be represented by the structure
MZ-LZ-Q. L 2
is a linker selected from the group consisting of a lower alkylene (e.g., Cl-
Cg alkylene),
sulfonamide, amide, quaternary ammonium, pyridinium, ester, ether, sulfide,
sulfone,
phenylene, urea, thiourea, urethane, amine, and a combination thereof. The
quencher may be
linked to M2 at one or two sites in some embodiments.

100731 For the polymeric quencher precursors, multiple options are available
for
attaching the boronic acid moiety and a reactive group which may be a
polymerizable group
or a coupling group to two different nitrogens in the beteroaromatic centrally
located group.
These are:
a) a reactive group on a first aromatic moiety is attached to one nitrogen and
a
second aromatic group containing at least one -B(OH)2 group is attached to the
second
nitrogen;

-16-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
b) one or more boronic acid groups are attached to a first aromatic moiety
which
is attached to one nitrogen and one boronic acid and a reactive group are
attached to a second
aromatic group which second aromatic group is attached to the second nitrogen:
c) one boronic acid goup and a reactive group are attached to a first aromatic
moiety which first aromatic group is attached to one nitrogen, and a boronic
acid group and a
reactive group are attached to a second aromatic moiety which is attached to
the second
nitrogen; and
d) one boronic acid is attached to each nitrogen and a reactive group is
attached
to the heteroaromatic ring.
100741 Preferred embodiments comprise two boronic acid moieties and one
polymerizable group or coupling group wherein the aroinatic group is a benzyl
substituent
bonded to the nitrogen and the boronic acid groups are attached to the benzyl
ring and may be
in the ortho- meta or para- positions.

[0075] In some einbodirnents, the boronic acid substituted viologen as a
discrete
compo-und useful for in vitro sensing may be represented by one of the
following fornnulas:
/ \ 0 ZXO
o N- NOo
Y'-(CH2)n n(H2C)-Y2
/ ~ - ~
Y'-(CFiz)n`-oN ~ ~N-(H2C)-YZ
2XO

O+/ \ -
Y~-(CHZ}õ-N \ /
NO
_
2X~ n(tipC)-Y2

100761 where n 1-3, X is halogen, and Y' and YZ are independently selected
from phenyl boronic acid (o- m- or p-isomers) and naphthyl boronic acid_ In
other
embodiments, the cluench.er may comprise a boronic acid group as a substituent
on the
heterocyclic ring of a viologen.
100771 A specific example used with TSPP is m-BBV:
-17-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330

N\ / \ /N'
B(OH)~ ( HO)2B

m-BBV
100781 The quencher precursors suitable for making sensors may be selected
from
the folIowiiig:

4x0
~N ~ ~ B(OH)z
~ \
~ i ~ \ I ~~
B(OH)2

2X D
-D
(k0
)2B(O}i)2
OOJ$I1II)

O~
NH
O
NH
+
~ / \ \
/ \N D N\

4X pi \ o

ND
( )zB B(OH)2 (HO)2B 2X 6(DH)2
0 0
NH NH

\ / \ N _
~
2 0 ~y
B(OH)2 (HO)Zs (HQ)zB B(OH)2
-18-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
o~
11H
0
NH
F F
O
B(OH)2 2X (HC)}28

NH
O O
2X NH
a/ T
(HO)z8 N \ ~ /
pN
p
(HO)2B

NH
2Br NH

N._ N
(H0)2B b C B(OH)2
3,3'-oBBV

100791 The quencher precursor 3,3-oBBV may be used with HPTS-LysMA or
HPTS-CysMA to make hydrogels in accordance with prefeiTed aspects of the
invention.
100801 Preferred quenchers are prepared from precursors comprising viologens

derived from 3,3'-dipyridyl substituted on the nitrogens with benzylboronic
acid groups and
at other positions on the dipyridyl rings with a polymerizable group or a
coupling group.
Representative viologens include:

-19-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
L-Z

CC
N N} -
R,/ X Rõ R' R"

10081] where L is Ll or L2 and is a linking group
10082] Z is a reactive group; and

[0083] R' is --B(OH)2 in the ortho- ineta- or para- positions on the benzyl
ring and
R" is H- ; or optionally R'' is a coupling group as is deflned herein or a
substituent
specifically used to modify the acidity of the boronic acid such as fluoro- or
rnethoxy-

100841 L is a divalent moiety that covalently connects the sensing moiety to a
reactive group that is used to bind the viologen to a polymer or matrix.
Examples of L
include those which are each independently selected from a direct bond or, a
lower alkylene
having I to $ carbon atoms, optionallv terminated with or interrupted by one
or more divalent
connecting groups selected from sulfonamide (-SOZNH-), amide -(C-O)N-, ester -
(C=O)-O-,
ether -0-, sulfide -S-, sulfone (-SO2-), phenylene -C6H4-, urethane -NH(C=O)-0-
, urea -
NH(C=O)NH-, thiourea -NH(C=S)-NH-, amide -(C-O)NH-, amine -NR- (where R is
defined
as alkyl having I to 6 carbon atoins) and the like.
100851 Z is either a polymerizable ethylenically unsaturated group selected
from
but not limited to methacrylarnido-, acrylamido-, inethacryloyl-, acryloyl-,
or styryl- or
optionally Z is a reactive functional group, capable of forming a covalent
bond with a
polymer or matrix. Such groups include but are not limited to -Br, -OH, -SH, -
CO2H, and -
NHz.
[0086] Boronic acid substituted polyviologens are another class of preferred
quenchers. The term polyviologen ineludes: a discrete compound comprised of
two or more
viologens covalently bonded together by a linking group, a polymer comprised
of viologen
repeat units in the chain, a polymer with viologen groups pendant to the
chain, a dendrimer
comprised of viologen units, preferably including viologen terminal groups, an
oligomer
comprisecl of viologen units, preferably including viologen endgroups, and
combinations
thereof. Polymers in which mono-viologen groups form a minor component are not
included.
-20-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
The preferred quenchers are water soluble or dispersible polymers, or
crosslinked,
hydrophilic polymers or hydrogels sufficiently permeable to glucose to
function as part of a
sensor. Alternatively the polyviologen boronic acid may be directly bonded to
an inert
substrate.

[0087] A polyviologen guencher as a polymer comprised of viologen repeat units
has the formula:

2Br
O / ~ O
N N

B[(OH)2 n

100881 In another embodiment, the polvviologen boronic acid adducts are formed
by covalently linking two or more viol ogen/boroni c acid intermediates. The
bridging
group is typically a small divalent radical bonded to one nitrogen in each
viologen, or to a
carbon in the aromatic ring of each viologen, or one bond may be to a ring
carbon i_n one
viologen and to a nitrogen in the other. Two or rnore boronic acid groups are
attached to the
polyviologen. Optionally, the polyviologen boronie acid adduct is substituted
with a
polymerizable group or coupling group attached directly to the viologen or to
the bridging
group. Preferably the polyviologen moiety includes only one such group.
Preferably, the
bridging group is selected to enhance cooperative binding of the boronic acids
to glucose.

10089] The coupling moiety is a linking group as defined previously with the
proviso that the linking group is optionally further substituted with a
boronic acid, a
polymerizable group, an additional coupling group, or is a segment in a
polymer chain in
which the viologen is a ehain unit, a pendant group, or any combination
thereof
Immobilizing Means

[0090] In some embodiments, for use in vilro not involving a moving stream,
the
sensing components are used as individual (discrete) components. The dye and
quencher are
inixed together in liquid solution, analyte is added, the change in
fluorescence intensity is
measured, and the components are discarded. Polyineric matrices that can be
used to trap the
-21-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
sensing components to prevent leaching need not be present. Optionally, the
sensing
components are imrnobilized which allows their use to measure analytes in a
moving stream.

100911 For in vivo applications, the sensor is used in a moving stream of
physiological fluid which contains one or more polyhydroxyl organic compounds
or is
implanted in tissue such as muscle which contains said compounds. Therefore,
it is preferred
that none of the sensing moieties escape from the sensor asseinbly. Thus, for
use in vivo, the
sensing components are preferably part of an organic polyiner sensing
assembly. Soluble
dyes and quenchers can be confned by a semi-permeable membrane that allows
passage of
the analyte but blocks passage of the sensing moieties. This can be realized
by using as
sensing moieties soluble molecules that are substantially larger than the
analyte molecules
(molecular weight of at least twice that of the analyte or greater than 1000
preferably greater
than 5000); and employing a selective semipermeable membrane such as a
dialysis or an
ultrafiltration membrane with a specific 3-nolecular weight cutoff between the
two so that the
sensiiig moieties are quantitatively retained.

10092J Preferably the sensing moieties are immobilized in an insoluble polymer
matrix, whicli is freely permeable to glucose. The polymer matrix is comprised
of organic,
inorganic or combinations of polymers thereof. The matrix may be composed of
biocompatible materials. Alternatively, the matrix is coated with a second
biocompatible
polymer that is permeable to the analytes of interest.

100931 The function of the polymer matrix is to bold together and immobilize
the
fluorophore and quencher moieties while at the same time allowing contact with
the analyte,
and binding of the analyte to the boronic acid. To achieve this effeet, the
matrix must be
insoluble in the medium, and in close association with it by establishing a
high surface area
interface between matrix and analyte solution. For example, an ultra-thin film
or
microporous support matrix is used. Alternatively, the matrix is swellable in
the analyte
solution, e.g. a hydrogel matrix is used for aqueous systems. ]n some
instances, the sensing
polymers are bonded to a surface such as the surface of a light conduit, or
impregnated in a
microporous membrane. In all cases, the matrix inust not interfere with
transport of the
analyte to the binding sites so that equilibrium can be established between
the two phases.
Techniques for preparing ultra-thin films. microporous polymers, microporous
sol-gels, and
-22-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
hvdrogels are established in the art. All useful matrices are defined as being
analyte
perineable.
100941 Hydrogel polymers are used in some embodiments. The term, hydrogel, as
used herein refers to a polymer that swells substantially, but does not
dissolve in water. Such
hydrogels may be linear, branched, or network polymers, or polyelectrolyte
complexes, with
the proviso that they contain no soluble or leachable fractions. Typically,
hydrogel networks
are prepared by a crosslinking step, which is performed on water-soluble
polymers so that
they swell but do not dissolve in aqueous media_ Alternatively, the hydrogel
polyiners are
prepared by copolymerizing a mixture of hydrophilic and crosslinking monomers
to obtain a
water swellable network polymer. Such polymers are formed either by addition
or
condensation polymerization, or by combination process. In these cases, the
sensing moieties
are incorporated into the polymer by copolymerization using monomeric
derivatives in
combination with network-forrning monomers. Alternatively, reactive moieties
are coupled
to an already prepared matrix using a post polyrnerization reaction. Said
sensing moieties are
units in the polymer chain or pendant groups attached to the chain.
[0095J The hydrogels useful in this invention are also monolithic polymers,
such
as a single network to whlch both dye and quencher are covalently bonded, or
multi-
component hydrogels. Multi-component hydrogels include interpenetrating
networks,
polyelectrolyte complexes, and various other blends of two or more polymers to
obtain a
water swellable composite, which includes dispersions of a second polyrner in
a hydrogel
rnatrix and alternating microlayer assemblies.
100961 Monolithic hydrogels are typically formed by free radical
copolymerization of a mixture of hydrophilic monomers, including but not
limited to HEMA,
PEGMA, methacrylic acid, hydroxyethyl acrylate, N-vinyl pyrrolidone,
acrylamide, N,N'-
dimethyl acrylamide, and the like; ionic monomers include
methacryloylaminopropyl
trimethylammonium chloride, diallyl dimethyl ammonium. chloride, vinyl benzyl
trimethyl
ainmonium chloride, sodium sulfopropyl methacrylate, and the like;
crosslinkers include
ethylene dimethacrylate, PEGDMA, trimethylolpropane triacrylate, and the like.
The ratios
of monomers are chosen to optimize network properties including permeability,
swelling
index, and gel strength using principles well established in the art. In one
embodiment, the
-23-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
dye moiety is derived from an ethylenically unsaturated derivative of a dye
molecule, sueh as
8-acetoxvpyrene-1,3,6-N, N', N"-tris(methacrylamidopropylsu3fonamide) the
quencher
moiety is derived from an ethylenically unsaturated viologen such as 4-N-
(benzyl-3-boronic
acid)-4'-N'-(benzyl-4ethenyl)-dipyridinium dihalide (m-SBBV) and the matrix is
made from
HEMA and PEGDMA. The concentration of dye is chosen to optimize emission
intensity.
The ratio of quencher to dye is adjusted to provide sufficient quenching to
produce the
desired measurable signal.
100971 In some embodiments, a monolithic hydrogel is formed by a condensation
polymerization. For example, acetoxy pyrene trisulfonyl chlorade is reacted
with an excess of
PEG diamine to obtain a tris-(amino PEG) adduct dissolved in the unreacted
diamine. A
solution of excess trimesoyl chloride and an acid acceptor is reacted with 4-N-
(benzyl-3-
boronic acid)-4'-N'-(2 hydroxyethyl) bipyridinium dihalide to obtain an acid
chloride
functional ester of the viologen. The two reactive mixtures are brought into
contact with
each other and allowed to react to form the hydrogel, e.g. by casting a thin
film of one
mixture and dipping it into the other.
10098] In other embodiments, multi-component hydrogels wherein the dye is
incorporated in one component and the quencher in another are preferred for
making the
sensor of this invention. Further, these systems are optionally molecularly
imprinted to
enhance interaction between components and to provide selectivity for glucose
over other
polyhydroxy analytes. Preferably, the multicomponent system is an
interpenetrating polymer
network (IPN) or a semi-interpenetrating polymer network (semi-IPN).
100991 The IPN polymers are typically made by seguential polymerization.
First,
a network comprising the quencher is formed. The network is then swollen with
a mixture of
monomers including the dye monomer and a second polymerization is carried out
to obtain
the IPN hydrogel.
101001 The semi-IPN hydrogel is formed by dissolving a soluble polymer
containing dye moieties in a mixture of monomers including a quencher monomer
and
polyrnerizing the mixture. In some embodiments, the sensing moieties are
immobilized by an
insoluble polymer matrix which is freely permeable to polyhydroxyl compounds.
Additional
details on hydrogel systems have been disclosed in US Patent Publications Nos.
-24-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
US2004/0028612, and 2006/0083688 which are hereby incorporated by reference in
their
entireties.
101011 The polymer matrix is comprised of organic, inorganic or combinations
of
polymers thereof. The matrix may be composed of biocompatible materials.
AltemativeIy,
the matrix is coated with a second biocompatible polymer that is permeable to
the analytes of
interest. The function of the polymer matrix is to hold together and
immobilize the
fluorescent dye and quencher moieties while at the same time allowing contact
with the
analytes (e.g., polyhydroxyl compounds, H+ and OH-), and binding of the
polyhydroxyl
compounds to the boronic acid. Therefore, the matrix is insoluble in the
medium and in close
association with it by establishing a high surface area interface between
matrix and analyte
solution. The matrix also does not interfere with transport of the analyte to
the binding sites
so that equilibrium can be established between the two phases. In one
embodiment, an ultra-
thin film or microporous support i-natrix may be used. In another
einbodiinent, the matrix
that is swellable in the analyte solution (e.g. a hydrogel matrix) can be used
for aqueous
systems. In some embodiments, the sensing polymers are bonded to a surface
such as the
surface of a light conduit, or impregnated in a microporous membrane.
Techniques for
preparing ultra-thin films, microporous polymers, microporous sol-gels, and
hydrogels have
been established in the prior art.
[01021 In one preferred embodiment, the boronic acid substituted viologen may
be covalently bonded to a fluorescent dye. The adduct may be a polymerizable
compound or
a unit in a polymer. One such adduct for example may be prepared by first
forming an
unsymmetrical viologen from 4,4'-dipyridyl by attaching a benzyl-3-boronic
acid group to
one nitrogen and an aminoethyl group to the other nitrogen atom. The viologen
is condensed
sequentially first with 8-acetoxy-pyrene-1,3,6-trisulfonyl chloride in a l:l
mole ratio
followed by reaction with excess PEG diamine to obtain a prepolymer mixture.
An acid
acceptor is included in both steps to scavange the byproduct acid. The
prepolymer rnixture is
crosslinked by reaction with a polyisocyanate to obtain a hydrogel. The
product is treated
with base to remove the acetoxy blocking group. lncomplete reaction products
and unreacted
starting materials are leached out of the hydrogel by exhaustive extraction
with deionized
-25-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
water before further use. The product is responsive to glucose when used as
the sensing
component as described herein.
101031 Alternatively, such adducts are ethylenically unsaturated 3-nonomer
derivatives. For example, dirnethyl bis-bromomethyl benzene boronate is
reacted with excess
4,4'-dipyridyl to form a half viologen adduct. After removing the excess
dipyridyl, the adduct
is further reacted with an excess of bromoethylamine hydrochloride to form the
bis-viologen
adduct. This adduct is coupled to a pyranine dye by reaction with the 8-
acetoxypyrene-tris
sulfonyl chloride in a 1:1 mole ratio in the presence of an acid acceptor
followed by reaction
with excess aminopropylmethacrylamide. Finally, any residual amino groups may
be reacted
with methacrylol chloride. After purification, the dye/viologen monomer may be
copolyznerized with HEMA and PEGDMA to obtain a hydrogel.

Ratiometric pHSensing
101041 Ratiometric pH sensing is known. See e.g., US Pat. Publication Nos.
2006/0105174; 2005/0090014; incorporated berein in their entirety by
reference. Given an
indicator system comprising a fluorophore (e.g., a fluorescent indicator dye)
that exists in two
forms (an acid form and a base form) the ratio of the emission intensity at
the two
wavelengths can be used to measure pH independent of the fluorophore
concentration. The
fluorescent indicator dyes suitable for ratiometric pH sensing may be: (1)
dyes that exhibit
dual excitation wavelengths (corresponding to acid and conjugate base forms)
and single
emission wavelengths (e.g., HPTS dyes); (2) single excitation wavelengths and
dual emission
wavelengths (acid and base forms); or (3) dual excitation - dual emission
dyes. Some dyes,
such as the SNARF or SNAFL dyes may have both dual-emission and dual-
excitation
properties. However a dual-dual dye, e.g., SNARF can be used as a single-dual
or a dual-
single.
101051 Dual emission fiber-optic sensors based on seminapthofluorescein and
carboxynaphthofluorescein have been described that rapidly and reliably
correlate intensity
ratios to pH. See e.g., respectively, Xu, Z., A. Rollins, et al. (1998) "A
novel fiber-optic pH
sensor incorporating carboxy SNAFL-2 and fluorescent wavelength-ratiometric
detection"
Journal of Biomedical Materials Research 39: 9-15, and Song, A., S. Parus, et
al. (1997)
"High-performance fiber-optic pH microsensors for practical physiological
measurements
-26-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
using a dual-emission sensitive dye" Analytical Chemistry 69: 863-867. The
extensive
photobleaching observed for these dyes may be accounted for by the ratiometric
approach,
but it would still limit the useful lifetime of the sensor.
101061 The fluorescent dye 8-hydroxy-1,3,6-pyrene trisulphonic acid trisodium
salt (HPTS) consists of a pyrene core with three sulfonic acid groups and a
hydroxyl group
that imparts pH sensitivity around a pKa of approximately 7.3 (Wolfbeis, O.
S., E.
Fuerlinger, et al. (1983). "Fluorimetric analysis. I_ Study on fluorescent
indicators for
measuring near neutral ('physiological') pH values." Fresneius' Z. Anal. Chem.
314(2): 119-
124); Wolfbeis et al, also have several patents on immobilized HPTS. Yafuso
and Hui
describe another immobilized fluorescent dye pH sensor in US Pat. No_
4,886,338;
incorporated herein in its entirety by reference thereto. HPTS exhibits two
excitation
wavelengths, one at 405 nm and one at 457 nm, that correspond to the acid and
its conjugate
base (Agayn, V_ 1. and Dr. R. Walt (1993). "Fiber-optic sensor for continuous
monitoring of
fennentation pH." Biotechiiology 72(6):6-9). The subsequent pH-dependent shift
in
excitation maximum about the pKa of 7.3 enables dual -excitation/ single
emission ratiometric
detection in the physiological range. This, together with a low toxicity
(Lutty, G. A_ (1978).
"The acute intravenous toxicity of stains, dyes, and other fluorescent
substances." Toxical
Pharmacol. 44: 225-229) and insensitivity to oxygen concentration (Zbujun, Z_
and W. R.
Seitz (1984). "A fluorescence sensor for quantifying pH in the range from 6.5
to 8.5."
Analytical Chimica Acta 160: 47-55), makes HPTS a suitable probe for
physiological and
bioprocess pH measurements.
10107] The presence of the three strongly anionic sulphonic acid groups allows
for HPTS to be immobilized by ionic binding to cationic supports. To date,
covalent
attachment of HPTS has been via sulfonamide coupling (U.S. Pat. No.
4,798,738). While
effective in immobilizing the dye and preserving pH sensitivity, polymer
substrates are
limited to those that contain primary amines. In addition, amine groups which
remain on the
substrate after coupling will affect the local pH inside the polymer matrix.
The dye has been
covalently attached to controlled pore glass (4ffenbacher, H., O. S. Wolfbeis,
et al_ (1986).
"Fluorescence optical sensors for continuous determination of near-neutral pH
values."
Sensor Actuator 9: 73-84) and aminoethyl cellulose (Schulman, S. G., S. Chen,
et al. (1995).
-27-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
"Dependence of the fluorescence of immobilized 1-hydroxypyrene-3,6,8-
trisulfonate on
solution pH: extension of the range of applicability of a pH fluorosensor."
Anal Chim Acta
304: 165-170) in the development of fluorescence-based pH sensors that operate
in neutral
and acidic environments, as well as an intravascular blood gas monitoring
system where it
was used for both pH and pCO2 detection (Gehrich, J. L., D. W. Lubbers, et al.
(1986).
"Optical fluorescence and its application to an intravascular blood gas
monitoring system."
IEE TBio-med Eng BME-33: 117-132). Fiber-optic pH sensors have been described
with
HPTS bound to an anion exchange membrane (Zhujun, Z. and W. R. Seitz (1984))
or resin
(Zhang, S., S. Tanaka, et al. (1995). "Fibre-optical sensor based on
fluorescent indicator for
monitoring physiological pH values." Med Biol Eng Comput 33: 152-156) and
fixed to the
tip of the optical fiber.
101081 For example U.S. Pat. No. 5,114,676 (incorporated by reference herein
in
its entirety) provides a pH sensor with a fluorescent indicator which may be
covalently
attached to a particle or to a microcrystalline cellulose fiber_ The sensor
comprises an
optically transparent substrate, a thermoplastsc layer and a hydrogel. Part of
the particle with
the indicator attached thereto is imbedded in a therrmoplastic layer that is
coated on the
substrate and mechanically adhered using heat and pressure. The majority of
the
particle/indicator is imbedded within a hydrogel layer that is applied over
the thermoplastic
layer. The pH sensor is applied to the tip of an optical waveguide.
101091 Furthermore, with the recent availability of low cost UV LEDs, the dye
can be measured with relatively inexpensive instrumentation that combines UV
and blue
LEDs and a photodiode module. Such a setup has been described (Kostov, Y., P.
Harms, et
al. (2001). "Low-cost microbioreactor for high-throughput bioprocessing."
Biotechnol
Bioeng 72: 346-352) to detect the pH of a high throughput microbioreactor
system via HPTS
directly dissolved in the fermentation media.
101101 In one embodiment of the present invention, the preferred sensing
device
comprises at least one light source, a detector, and a sensor comprising a
fluorescent reporter
dye system. In one embodiment, the fluorescent reporter dye system comprises a
fluorescent
dye operably coupled to an analyte-binding quencher. The dye may be covalently
bound to
the quencher or merely associated with the quencher. The dye and quencher are
preferably
-28-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
operably coupled, which means that in operation, the cluencher is in close
enough proximity
to the dye to interact with and modulate its fluorescence. In one embodiinent,
the dye and
quencher may be constrained together within an analyte-penneable hydrogel or
other
polymeric matrix. When excited by light of appropriate wavelength, the
flvorescent dye
emits light (e.g., fluoresces). The intensity of the light is dependent on the
extent of
cluenching which varies with the amount of analyte binding. In other
embodiments, the
fluorescent dye and the quencher may be covalently attached to hydrogel or
other polymeric
matrix, instead of to one another.
[0111] ln one embodiment, a separate pH indicator dye is combined with a
different dye that is functionalized with an analyte-binding moiety, such that
the two dye
system are immobilized togetlier (e.g., in a hydrogel) in the sensor.
101121 Some fluorescent pH indicator molecules absorb light at a particular
wavelength and emit light at a second, longer wavelength. Their pH indicating
function
typically involves protonation and deprotonation. This means that -these
'#luorescent pH
indicators include a hydrogen atom (proton, H+) which forms part of the
molecule (is bound
to the molecule) in one pH range, but within another pH range the proton is
dissociated from
the molecule_ When the proton is disassociated from the molecule, the molecule
takes on a
negative charge, which is balanced by a positively-charged ion (e.g., Na+) in
solution with the
indicator. This arrangement is illustrated by Equation 1. R-H > R+H+

(0113} Where R represents a fluorescent molecule, it generally will exhibit
fluorescence at a different wavelength (will be visible as a very different
color) based upon
whether it is in the R H form or in the R form. For most molecules represented
by R, this
change will occur generally quite abruptly within a very narrow pH range,
allowing R to
serve as a very simple and reliable pH indicator. When placed in solution, it
will exhibit one
very distinct color (a color associated with its R--H form), and another very
distinct color
associated with its R _
101141 For example, 8-Hydroxyl-1,3,6-pyrenetrisulphonate (HPTS) has been
considered one of the best potential indicators for pH determination because
of its excellent
photo-stability, high quantum yield, dual excitation, large Stokes' shift and
long fluorescence
emission. A desirable feature of this indicator is that the acidic (associated
HPTS form) and
-29-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
basic (dissociated PTS-) forms have different excitation wavelengths at 406
and 460 nm,
with an isosbestic point at 418 nm, but exhibit a similar fluorescence
emission maximum at
515 nm. The dual excitation and single einission make HPTS suitable for
ratiometric
detection of pH. The fluorescence intensity at 406 nm for the acid form
decreases but the
intensity at 460 nm for the base form increases as the pH is raised
accompanying the
conversion of the acidic into basic forms of the dye.

101151 Due to the hydroxyl (-OH) group on dyes such as HPTS and its
derivatives, these dyes are sensitive to the pH changes in the environment.
The pH-
dependent ionization of the hydroxyl group causes these pyranine derivatives
to have a pH-
dependent absorption spectra with different absorption maxima in its acidic
form and basic
form. The first absorption maximum is the first excitation wavelength and the
second
absorption maximum is the second excitation wavelength. The arnounts of light
absorbed by
the fluorescent dye at the first excitation wavelength and the second
excitation wavelength
depend on or relate to the pH of the medium the fluorescent dye is in contact
with. The
amount of light emitted by the dye (e.g., the fluorescent emission) at the
emission wavelength
depends on the amount of light absorption when the dye is irradiated at the
excitation
wavelength. Since the absorption is affected by the pH of the medium, the
fluorescent
emission is also affected by the pH. This provides the basis for the pH
determination while
being able to measure the polyhydroxyl compound concentration.

101161 In one preferred ernbodiment of the present invention, ratiometric pH
sensing is accomplished using an optical sensor comprising at least one
excitation light
source operably coupled to the proximal end region of an optical fiber,
wherein the fiber has
disposed along its distal end region within the light path of the fiber, an
indicator system
configured to generate a detectable emission signal in response to the
excitation light.
Preferred embodiments of the sensor further comprise optical means for sending
the emission
signal to a detector. Such optical means are well known in the art, and may
involve e.g., a
mirror to return light, filters, lens, beam splitters, and optical fiber
bundles and split
configurations.

[0117] In preferred embodiments, the indicator system comprises a fluorophore
that exhibits at least two different forms and a pH-dependent shift between
these different
-30-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
forms, wherein this shift can be detected as a change in the emission
intensity at a single
wavelength or at two different wavelengths. For example, one indicator system
for
ratiometric pH sensing comprises an fluorescent dye (e.g., HPTS) that absorbs
light at two
different wavelength maxima's (7,cid and Xbase) depending on whether the dye
is in its acid or
base forms, and it emits light at a single longer emission wavelength. More
particularly, as
pH is increased, HPTS shows an increase in absorbance corresponding to the
Xbase and a
decrease in absorbance corresponding to the ~.acid= These changes are due to
the pH-
dependent ionization of the hydroxyl group. The emission spectrum for HPTS is
independent
of pH, with a peak emission wavelength of about 511 nm, but the intensity of
the emitted
light depends on the amount of light absorbed (which varies with pH and the
excitation
wavelength). So for example, if one excites HPTS at a given pH with light of a
first
wavelength (e.g., Xn;d), one can measure the emission intensity at the single
emission
wavelength; the intensity will depend on the form of the dye (i.e., degree of
ionization -
which depends on the pH). One can also excite at a second wavelength (e.g.,
Xba$. ) and
measure the emission intensity at the same given pH. The ratio of the emission
intensities
relates to the pH and is independent on the amount of the dye as well as
certain optical
artifacts in the system. It is noted that any excitation wavelengths may be
used for the
ratiometric sensing, but theXnid and Xbase are preferred in accordance with
one embodiment of
the invention. The wavelength at which the absorption is the same for the acid
and base
forms of the dye is called the isobestic point-excitation at this wavelength
(k;SO) may also be
used in ratiometric sensing in accordance with other preferred variations to
the invention.
When a ratio of emission intensities (e.g., IbaA;so or IbasWlnid) is plotted
against pH, a
standard or calibration curve is generated (See e.g., FIGS. 3, 5 and 9). The
ratiometric
method is similar regardless of whether the dye used is a dual exciter-single
emitter (like
NPTS), or a single exciter dual emitter, or a dual exciter-dual emitter, as
long as the dye
undergoes a pH sensitive shift in form that yields a detectable change in
spectral property.
Optical Glucose Sensing
101181 Indicator systems comprising fluorescent dyes, including HPTS and its
derivatives, have been used in analyte detection. See e.g., U.S. Pat. Nos.
6,653,141,
6,627,177, 5,512,246, 5,137,833, 6,800,451, 6,794,195, 6,804,544, 6,002,954,
6,319,540,
-31-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
6,766,183, 5,503,770, and 5,763,238; and co-pending U.S. Patent Application
Nos.
1 I/296,898 and 601833,081 : each of which is incorporated herein in its
entirety by reference
thereto. In particular, details related to soine preferred fluorescent dyes,
guenchers/analyte
binding moieties, and inethods for optically determining polyhydroxyl compound
concentrations are disclosed in U.S. Pat. Nos. 6,653,141 and 6,627,177, and
U.S. Pat.
Application Nos. ] 11296,898 and 60/833,081.
Device for lntravascular Detei7nination of pH and Glucose
101 191 In one embodiment, the method and sensor monitor the pH of the media
and the concentration of analyte in vitro. In another embodiment, the method
and sensor
monitor pH and analyte concentration in vivo. In another embodiment, the
measured pH
value can also be used to more correctly determine glucose eoncentration in
vitro or in vivo.
Specifically, the simultaneous measurexnent of the pH value and the glucose
concentration
would enable real time correction of the signal of glucose response. Although
it will be
appreciated that the device in accordance with sonie embodiments comprise a
sensor that
may be used only to determine pH or analyte (correction of which for pH may be
done by
conventional two sensor technologies or by testing the blood pH in vitro).
101201 One embodiment provides a device for determining pH and the
concentration of a polyhydroxyl compound simultaneously, comprising a sensor
comprising a
fluorescent dye operably coupled to a quencher; means for delivering one or
more excitation
wavelengths to said sensor; and means for detecting fluorescence emission from
said sensor.

[0121) Another embodiment provides a device for determining the pH and the
polyhydroxyl compound concentration in a physiological fluid, comprising a
water-insoluble
polymer matrix, wherein said polymer matrix is permeable to polyhydroxyl
compound; a
fluorescent dye associated with said polymer matrix, wherein the fluorescent
dye is
configured to absorb light at a first excitation wavelength and a second
excitation
wavelength, and to emit light at an emission wavelength; a quencher comprising
an aromatic
boronic acid substituted viologen, adapted to reversibly bind an amount of
polyhydroxyl
compound dependent on the polyhydroxyl compound concentration, wherein said
quencher is
associated with said polymer inatrix and operably coupled to the fluorescent
dye, and wherein
the quencher is conf g-ured to reduce the light intensity emitted by said
fluorescent dye related
-32-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
to the amount of bound polyhydroxyl compound; at least one excitation light
source; and an
emission light detector.
10122] In one aspect, the present invention comprises a class of fluorescence
quenching compounds that are responsive to the presence of polyhydroxyl
compounds such
as glucose in aqueous media at or near physiological pH. In other words, the
quenching
efficiency is controlled by the concentration of these compounds in the
medium. Preferred
quenchers comprise a viologen substituted with at least one boronic acid group
wherein the
adduct is immobilized in or covalently bonded to a polymer. The quencher, dye
and polymer
may also be covalently bonded to each other. In another aspect, the present
invention
comprises a class of fluorescent dyes which are susceptible to quenching by
the
viologen/boronic acid adduct.
101231 The fluorescent dye and quencher are operably coupled to each other for
polyhydoxyl compound sensing. The dye and quencher may be linked through a
polymer
backbone in some embodiments_ In other eanbodiments, the dye and quencher
could be in
close proximity to each other for the quenching of the fluorescent dye to
occur, thereby
reducing the fluorescent emission of the dye. VJhen polyhydroxyl compound
(e.g., glucose)
binds to the boronic acid to form boronate ester, the boronate ester interacts
with the viologen
and alters its quenching efficacy according to the extent of polyhydroxyl
compound binding.
As a result, the intensity of fluorescent emission increases as more
polybydroxyl compounds
are bonded to the quenchers.
101241 In one preferred embodiment, the device comprises an optical fiber
cornprising a cavity disposed therein and having irnTnobilized within the
cavity an indicator
system as described above (e.g., a fluorophore operably coupled to a glucose
binding
moiety/quencher and an immobilizing polymeric matrix). The device further
comprises a
light source and a detector.
Methods for Simultaneous Determination of H and Glucose
101251 One embodiment provides a method for deterrnining the pH and the
polyhydroxyl compound concentration with one fluorescent dye, comprising
providing a
sensor comprising a fluorescent dye operably coupled to a quencher; contacting
said sensor
with a sample; irradiating said sensor at the frst excitation wavelength;
detecting a first
-33-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
fluorescence emission of said sensor at an emission wavelength; irradiating
said sensor at the
second excitation wavelength; measuring a second fluorescence emission of said
sensor at
said emission wavelength; comparing the ratio of the first and second
emissions with a pH
calibration curve to determine the pH of the sample; correlating the emission
quenching with
a standard curve at the known pH to determine the polyhydroxyl compound
concentration in
said sample. Of course other algorithms are known for ratiometric pN sensing
and may be
used in accordance with embodiments of the present invention. A controller,
such as a
computer or dedicated device, may be used in some embodiments to control the
operations,
including application of the excitation light, monitoring of detector signals,
determining
ratios, correlating ratios with calibration curves, correlating glucose
signals with standard
curves, correcting for pH changes, running routine sensor calibration
operations, prompting
operator actions, integrating user data input (e.g., finger stick glucose
measurements) as
programmed to maintain accuracy, etc.
[0] 26] With respect to Figure 1, a sensing device 100 in accordance with one
embodiment of the present invention comprises at least one light source Il
(e.g., an
excitation light source), a detector 15 (e.g., an emission light detector),
and a sensor 13
comprising a fluorescent dye operably coupled to a quencher and an optional
polymer matrix.
In some embodiments, the light source 11 may be adapted to selectively deliver
two or more
different wavelength for the excitations of fluorescent dyes. This type of
light source may be
a tunable light source. In other embodiments, one or more light sources may be
used in
conjunction with an optical filter 12 for attenuating the wavelengths. In
other embodiments,
more than one light source 11 may be used to deliver different excitation
wavelengths. Such
light source is also a means for delivering a first and a second excitation
wavelengths to the
sensor.
101271 The sensor 13 comprises a fluorescent dye that is sensitive to both the
pH
and the polyhydroxyl compound (e.g_, sugar or glucose) concentration of the
medium when
the dye is operably coupled to a quencher. Such fluorescent dye exhibits a
shift in excitation
wavelength maximum with a corresponding shift in pH of the local environment
of the
fluorescent dye. As the pH of the local environment changes, the absorption at
a first
excitation wavelength may increase, while the absorption at a second
excitation wavelength
-34-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
decreases, or vice versa. The change in absorption at a selected wavelength
can affect the
Ievel of fluorescence emission, therefore ultimately permitting pH detection.
The pH
detection is independent of the concentration of the polyhydroxyl compound in
the
environment. A suitable fluorescent dye is also susceptible to quenching by
molecules such
as viologens. When the fluorescent dye is operably coupled to a quencher
(e.g., a viologen),
the fluorescence emission is attenuated. The quencher may have an aromatic
boronic acid
moiety that is capable of providing glucose recognition. The boronic acid
reacts reversibly
with glucose in aqueous media to form boronate ester, and the extent of such
reaction is
related to the glucose concentration in the medium. As more glucose is
available to react
with the quencher, the quencher's ability to accept electron from the dye
decreases_ As a
result, the attenuation of fluorescence emission by the quencher is dependent
on the
concentration of the polyhydroxyl compound (e.g., glucose) to be detected.

[0128) A detector 15 is used to detect the fluorescent emission and in
preferred
embodiments, may be linked to the electronic control 20 for analysis. Optical
fllters,, e.g., 14,
can be placed between the sensor 13 and the detector 15 for wavelength
selection. Other
optical components may also be utilized, e.g., mirrors, collimating and/or
focusing lenses,
beam splitters, etc. Optical fibers can be used to deliver selected
wavelengths to the sensor
and to deliver the fluorescen:ce emission from the sensor to the detector. The
light source and
the detector may be controlled by electronic control 20 such as a computer.

[0129] One embodiment of this invention provides a method for measuring pH
and polyhydroxyl compound concentration with a single fluorescent dye.
Measurements can
be carried out in vitro or in vivo. It may be necessary to calibrate the
sensor prior to
performing the first measurement. This may be done by first acquiring the
absorbance
spectra of the sensor at various pHs to determine the wavelengths where
isobestic point and
absorption maxima for acid and base forms occur and then acquiring the
emission signals
from at least two of these wavelengths at at least one known pH and glucose
concentration.

101301 For the pH and polyhydroxyl concentration measurements, the sensor 13
is
first placed in contact with a sample. The sensor 13 is then irradiated at the
first excitation
wavelength followed by the second excitation wavelength. The first and second
excitation
wavelengths are typically chosen near the wavelength of the absorption maximum
for the
-35-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
acidic form of the fluorescent dye the wavelength of the absorption maxinium
for the
basic form of the fluoresceiit dye Plbase), or the wavelength of the isobestic
point (Xiso), or
other selected wavelength. Thc ratio of the emissions from the first and
second excitation
wavelengths are used to determine the sample pH. Either the first or second
emission, once
corrected for pH, can be used to determine the sample glucose concentration.
10I3I1 In variations to the sensing device shown in Figure I, the detector may
be
a standard photodiode detector. There may be two diode detectors, one for a
reference and
one for the emission signal. Instead of diode detectors, the optical fiber
carrying sensor
output (fluorescent emission and/or reflected excitation light) may provide
input directly to a
spectrophotometer or microspectrometer. In a preferred embodiment, the
detector comprises
ainicrospectrometer such as the UV/VIS Microspectrometer Module manufactured
by
Boehringer Ingelheim.
101321 Figure 2 shows one embodiment of an optical system that may be used in
accordance with preferred aspects of the present invention. With reference to
FIG. 2, certain
embodiments comprise at least two light sources, 301A and 301B. The light
sources generate
excitation light that may be transmitted (as illustrated) through collimator
lenses 302A and
302B. In certain embodiments, the resulting light from collimator lenses may
be transmitted
(as illustrated) to interference filters 303A and'303B. In certain
embodiments, the resulting
light from interference filters may be focused (as illustrated) by focusing
lenses 304A and
304B into fiber optic lines 305A and 305B. In certain embodiments, fiber optic
lines merge
into a single fiber 306 that is continuous with the sensor 307, having the
imbedded indicator
system 307A. The cross-sections of the fibers may vary (as illustrated) from a
bundle of
fibers surrounding a central optical fiber 306A to a single fiber 307A.
101331 In certain embodiments (as illustrated), the emission light signals
generated by the indicator system 307A as well as the excitation light signals
are reflected by
mirror 308 and transmitted back out of the sensor into the fiber optic outlet
lines 309 and
309A. In the illustrated system, the outlet lines are augmented by including
two interference
filters 312A, 312B and two detectors 313A, 3138. In preferred ernbodiments,
the
interference filter 312A is configured to block the excitation light and allow
the emission
light to pass to detector 313A where the emission light is detected. In
certain embodiments,
-36-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
the signal produced by the detector 313A is amplified by the amplifier 314A
and converted
into a digital signal by analog-to-digital converter 315A and transmitted to
computer 316. In
certain embodiments, the interference filter 312B is configured to block the
emission light
and allow the excitation lights to pass to detector 313B where the excitation
light is
measured. ln certain embodiments, the signal produced by the detector 313B is
amplified by
the amplifier 314B and converted into a digital signal by analog-to-digital
converter 315B
and transmitted to computer 316. Ratiornetric calculations may be employed to
substantially
eliminate or reduce non-glucose related factors affecting the intensity of the
emission light;
these methods are disclosed in detail in co-pending US Provisional Application
No.
60/888,477, entitled "Optical systems and methods for ratiometric measurernent
of glucose
using intravascular fluorophore sensors," filed herewith on the same day, and
incorporated
herein in its entirety by reference thereto.
EXAMPLES
101341 Example 1- Figure 3 shows an example of the cxcitation/absorption
spectrum of a fluorescent dye, in this case HPTS. From the absorption spectra
of the
fluorescent dye acquired at diff-erent pHs, Xa~,ia, kbase and X,50 can be
determined. At a lower
pH (e.g., more acidic condition), the peak at around 405 nm is higher than the
peak at around
460 nm, and is therefore the absorption maximum for the acidic form of the
fluorescent dye.
At a higher pH (e.g., more basic condition), the peak at round 460 nm is
higher than the peak
at around 405 nm, therefore is the absorption maximum for the basic form of
the fluorescent
dye. The ?L15L, would be the wavelength where the absorption is independent of
the pH, and it
would be, for example, around 422 nm for HPTS.

10135] The first fluorescence emission intensity (1x, which could be lae;a,
lbase or
I;SO) at a emission wavelength, resulting from the irradiation at the first
excitation wavelength
(e.g., Xac;d, a.base or ?.,So), is then measured by the detector and the
result is stored in the
electronic control. Then the sensor is again irradiated at the second
excitation wavelength.
The second excitation wavelength is different from the first excitation
wavelength and can
also be selected from ?tac,a, Xbase or Xiso. The detector will then
detect/measure the second
fluorescence emission intensity (Iy, which could be la,;a, Ibase or l;so)
resulting from the
irradiation at the second excitation wavelength (e.g., kac;a, kbase or Xiso).
The ratio of the first
-37-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
and the second fluorescence emissions (1,t/Iy) can then be computed. Since the
lX/ly is
independent from the polyhydroxyl concentration, a pH standard curve (Ix1Iy
vs. pH) can be
plotted without considering the effect of polyhydroxyl concentration.
101361 Example 2 HPTS/MABP4 -- Figure 4 shows independence of ratiometric
pH sensing using HPTS/MABP4 using the I(bQSe)/l(,so) ratio from glucose
concentration. The
structure of MABP4 is:

O 0
HN NH
4Br
G) /I
N NO
\ (D N-
~

B(OH)2 (F-kO)2B
MABP`j~
[0137] The data are plotted as a ratio of the fluorescence emission for

corresponding to excitation at 454 nm (base) and 422 nm (isobestic point) vs_
pH in various
glucose concentrations. The changes in glucose concentrations have no
diseernable effects on
the value of Ib1S,/I7, at each specific pH. Thus the pH of the sample can be
measured using a
standard curve of Ix/ly vs, pH, regardless of the polyhydroxyl compound
concentration in the
sample. By correlating or comparing the measured 1,,/Iy to the standard curve,
one may
deternnine the pH of the sample being measured.
[0138] Figure 5 shows glucose response curves for HPTS/MABP4 excited at 422
nm (isobestic point) at different pHs. By plotting the ratio of IX/Iy at
various glucose levels (1)
to 1X/Iy at zero glucose concentration (Ia) vs. glucose concentration, a
standard polyhydroxyl
response curve can be used to determine the glucose concentration in a sample
from
measured I/10 values. However, since 1/1() value is dependent on the pH of the
sample, the
standard glucose response curve can be affected by the different pH. To
circumvent this,
several standard glucose response curves at different pHs within the
pbysiological range can
-38-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
be plotted and available for selection by either the electronic control or the
operator of the
sensor device. When the lX/lv measurement of the sample is available, the
electronic control
or the operator would know the pH of the sample from the standard 1x1IY vs. pH
curve, and the
correct standard polyhydroxyl response curve (e.g., glucose response curve)
may be used for
determining the accurate glucose concentration. Although the examples shown in
the figures
concern determination of glucose concentration, the application of the method
and device of
the present invention is not limited to detecting glucose concentration. Since
the fluorescent
system responds to polyhydroxyl compounds the same way it responds to glucose,
the sensor
device can be used to detect any polyhydroxyl compound concentration and the
pH at the
same time.

101391 Example 3(SNARF-1) - Figure 6 shows the absorption spectra of
SNARF-1 at different pHs in solution. SNARF is a tradename for a class of
commercial dyes
from Molecular Probes, Inc. These experiments were carried out using SNARF-1.
Figures 7
and 8 show glucose response curves for SNARF-1/3,3'-oBBV in solution at
different pHs
determined at 514 mn excitationl5$7 nrn emission (Figure 7), or at 514 nm
excitation1625 nm
emission (Figure 8). Figure 9 shows ratiometric sensing of pH at different
glucose
concentrations with SNARF-I13,3'-oBBV in solution using the I(bQSe)/I(Q,;d)
ratio determined at
a single excitation wavelength of 514 nm and emission wavelengths of 587 and
625 nm.
Thus, the dual-dual dye SNARF-I may be used operably coupled to the quencher
3,3'-oBBV
(in solution) as a single exciter-dual emitter 17uorophore to determine both
pH ratiometrically
and glucose.

101401 Example 4(HPTS-triLysMA/3,3'-oBBVIDMAA) - Figure 10 shows the
glucose response of HPTS-tril.ysMA/3,3'-oBBV/DMAA indicator system at
different pHs.
Figure I I shows ratiometric sensing of pH at different glucose concentrations
with the
HPTS-triLysMA/3,3'-oBBVIDMAA indicator system, using the I(base)II(uc;d)
ratio. It can be
seen that this indicator system provides a linear pH curve over the
physiologic pH range.

[0141] Example 5(HPTS-triCysMAJ3,3'-oBBV/DMMA) - Figure 12 shows
ratiometric sensing of pH at different glucose concentrations with the HPTS-
triCysMA/3,3'-
oBBV/DMMA indicator system, using the 1(vu.sP)1I(Q,,d) ratio. It can be seen
that this indicator
system provides a linear pH curve over the physiologic pH range. For this
example, the
-39-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
indicator system was immobilized in a hydrogel eznbedded at the end of an
optical fiber. The
acid and base emission signals were measured using a hand-held detector.

101421 Lifetime Chemistry
101431 In another preferred embodiment, glucose concentrations can be
determined by exploiting the phenomena of fluorescence resonance energy
transfer (FRET).
FRET is the transfer of energy from a donor fluorophore to an acceptor
molecule. FRET
occurs when the donor fluorophore, which fluoresces at a wavelength absorbed
at least in part
by the acceptor molecule, is in close proximity to the acceptor such that the
donor
fluorophore can transfer energy to the acceptor through molecular
interactions. The
fluorescence lifetime of the fluorophore, where the fluorescence lifetime is
the time the
fluorophore remains in the excited state, is altered by FRET. Thus, measuring
the
fluorescence lifetime of the fluorophore allows one to determine whether the
fluorophore is
bound to the acceptor.
[0144] Lifetime can be measured by using a time-domain method where the
fluorophore is excited by a brief pulse of excitation ligbt and the
fluorescence intensity is
measured over time. The excitation pulse can be a pulse from a laser with a
duration in the
picoseconds range up to a duration of about a few nanoseconds. ln other
embodiments, the
pulse duration can be greater than about a few nanoseconds. The fluorescenee
intensity of
the fluorophore as a function of time is given by the equation:

l(t) = Io * exp(-t / z) Equation l

101451 I(t) is the fluorescence intensity at time (t), lo is the initial
intensity after
excitation and c is the fluorescence lifetime which is defined as the time
required for 1(t) to
decay to lo/e. Equation I is applicable to a fluorophore with a single
exponential decay of
fluorescence and a lifetime that is substantially longer than the excitation
pulse. Figure 13
shows a graph of the decay of the fluorescent emission 400 over time after a
pulse of
excitation light 402. The time it takes the initial intensity, lo, to drop to
10/e is equal to the
lifetime, -1.

-40-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
101461 An alternative method of ineasuring lifelime is by a frequency-domain
method where the fluorophore is excited by a frequency modulated excitation
light. The
fluorescence lifetime, 'r, can be determined by measuring the phase shift of
the emission from
the fluorophore relative to the excitation light, or by measuring the
modulation ratio, using
the following equations:

r~ = (v-' *tan(O) Equation 2
Equation 3
o) = 21r

zf,, = w-' *(1Y1 -z -1)1 2 Equation 4
(AC 1 DC) E 1? .
M = Equation 5
(ACI DC)L,v

zO is the lifetime detennined by measuring the phase shift, 0. c~ is the
angular
frequency of the frequency modulated excitation ligbt and f is the linear
frequency. r.' is
the lifetime determined by measuring the modulation ratio, M. AC is the
magnitude of the
alternating portion of the signal, or the amplitude of the wave, while DC is
the amplitude of
the DC portion of the signal. EM refers to the emission signal, and EX refers
to the
excitation signal. Figure 14 is a graph showing the relationship between the
emission signal
500 and the excitation signal 502 and the variables described in Equations 2-
5.
101471 Preferred binding assay configurations for use in the sensor include a
reversible competitive, reagent limited, binding assay, the components of
which include an
analyte analog and an analyte binding agent capable of reversibly binding both
the analyte of
interest and the analyte analog. The analyte of interest and the analyte
analog compete for
binding to the saine binding site on the analyte binding agent. SUCh
competitive binding assay
configurations are well known in the art of clinical diagnostics and are
described, by way of
example, in The lmmunoassay Handbook, ed. David Wild, Macmillan Press 1994.
Suitable
analyte binding agents for use in the assay would include antibodies or
antibody fragments
which retain an analyte binding site (e.g. Fab fragments), lectins (e.g.
concanavalin A),
hormone receptors, drug receptors, aptarners and molecularly-imprinted
polymers. Preferably
the analyte analog should be a substance of higher molecular weight than the
analyte such
-41-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
that it cannot freely diffuse out of the sensor. For example, an assay for
glucose might employ
a high molecular weight glucose polymer such as dextran as the analyte analog.
[0148] Suitable optical signals which can be used as an assay readout in
accordance with the invention include any optical signal which can be
generated by a
proximity assay, such as those generated by fluorescence resonance energy
transfer,
fluorescence polarisation, fluorescence quenching, phosphorescence technique,
luminescence
enhancement, lmninescence quenching, diffraction or plasmon resonance.
[01491 In some preferred embodiments of the sensor of the invention
incorporates
a competitive, reagent limited binding assay which generates an optical
readout using the
technique of fluorescence resonance energy transfer. In this assay format the
analyte analog is
labelled with a first chromophore and the analyte binding agent is labelled
with a second
chromophore_ One of the first and second chromophores acts as a donor
chromophore and the
other acts as an acceptor chromophore. It is an important feature of the assay
that the
fluorescence einission spectrum of the donor chromophore overlaps with the
absorption
spectrum of the acceptor chromophore, such that when the donor and acceptor
chromophores
are brought into close proximity by the binding agent a proportion of the
energy which
normally would produce fluorescence emitted by the donor chromophore
(following
irradiation with incident radiation of a wavelength absorbed by the donor
chromophore) will
be non radiatively transferred to the adjacent acceptor chromophore, a process
known in the
art as FRET, with the result that a proportion of the fluorescent signal
emitted by the donor
chromophore is quenched and, in some instances, that the acceptor chromophore
emits
fluorescence. Fluorescence resonance energy transfer will generally only occur
when the
donor and acceptor chromophores are brought into close proximity by the
binding of analyte
analog to analyte binding agent. Thus, in the presence of analyte, which
competes with the
analyte analog for binding to the analyte binding agent, the amount of
quenching is reduced
(resulting in a measurable increase in the intensity of the fluorescent signal
emitted by the
donor chromophore or a fall in the intensity of the signal emitted by the
acceptor
chromophore) as labelled analyte analog is displaced from binding to the
analyte binding
agent. The intensity or lifetime of the fluorescent signal emitted from the
donor chromophore
thus correlates with the concentration of analyte in the fluid bathing the
sensor.

-42-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
]0150] An additional advantageous feature of the fluorescence resonance energy
transfer assay format arises from the fact that any fluorescent signal emitted
by the acceptor
chromophore following excitation with a beam of incident radiation at a
wavelength within
the absorption spectrum of the acceptor chromophore is unaffected by the
fluorescence
resonance energy transfer process. lt is therefore possible to use the
intensity of the
fluorescent signal emitted by the acceptor chromophore as an internal
reference signal, for
example in continuous calibration of the sensor or to monitor the extent to
which the sensor
has degraded and thus indicate the need to replace the sensor. As the sensor
degrades, the
amount of acceptor chromophore present in the sensor will decrease and hence
the intensity
of fluorescent signal detected upon excitation of the acceptor chrornophore
will also decrease.
The fall of this signal below an acceptable baseline level would indicate the
need to implant
or inject a fresh sensor. Competitive binding assays using the fluorescence
resonance energy
transfer technique which are capable of being adapted for use in the sensor of
the invention
are known in the art. U.S. Pat. No. 3,996,345 describes immunoassays employing
antibodies
and fluorescence resonance energy transfer between a fluorescer-quencher
chromophoric
pair. Meadows and Schultz (Anal. Chim. Acta (1993 280: pp2l -30) describe a
homogeneous
assay method for the measurement of glucose based on fluorescence resonance
energy
transfer between a labelled glucose analog (FITC labelled dextran) and a
labelled glucose
binding agent (rhodamine labelled concanavalin A). ln all of these
configurations the
acceptor and donor chrornophores/quenchers can be linked to either the binding
agent or the
analyte analog.

10I511 Fluorescence lifetime or fluorescence intensity measurements may be
made. As described in Lakowitz et al, Analytica Chimica Acta, 271, (1993), 155-
164,
fluorescence lifetime may be measured by phase modulation techniques.

10152] In some preferred embodiments as shown in Figures 15A, 15B and I5C, a
competitive binding system to measure glucose using FRET comprises a glucose
binding
molecule 600 linked to a donor fluorophore 602 and a glucose analog 604 linked
to an
acceptor molecule 606. The glucose binding molecule 600 is capable of binding
with both
glucose 608 and the glucose analog 604. As shown in Figure 15A, when the
glucose analog
604 is bound to the glucose binding molecule 600, the fluorescent emission 500
from the
-43-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
fluorophore 602 is reduced in magnitude and shifted in phase and lifetime by
FRET 610
because the fluorophore 502 is in close proximity to the acceptor 606. In
other embodiments,
the fluorophore 602 is linked to the glucose analog 604 and the acceptor 606
is linked to the
glucose binding molecule 600.
101531 As shown in Figure 15B, glucose 608 competes with the glucose analog
604 for the binding site on the glucose binding molecule 600. As shown in
Figure 15C, the
glucose molecule 608 can displace the glucose analog 604 from the glucose
binding molecule
600 so that the acceptor 606 does not alter the emission lifetime 500 of the
fluorophore 602
via FRET 610.
101541 In a system where there are a certain concentration of glucose binding
molecules, glucose analogs and glucose molecules, an eguilibrium will exist
between the
number of bound glucose molecules to the number of bound glucose analogs. A
change in
the nuinber of glucose molecules in the system, changes the equilibrium
between bound
glucose molecules to bound glucose analogs. This in turn changes the mean
lifetime of the
fluorophore emission.
10155] In some preferred embodiments, the system is excited by a frequency
modUlated excitation light less than approximately 1 MHz, between
approximately I to 200
MHZ, or greater than approximately 200 MHz. In some embodiments, the frequency
is
approximately 0.05, 0.1, 1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120,
130, 140, 150,
160, 170, 180, 190 or 200 MHz. By measuring the degree of the phase shift of
the system, an
average FRET induced phase shift for the system can be determined which
corresponds to an
average lifetime value for the system as defined by Equations 2 and 3
described above. Both
the phase shift and the lifetime values can be correlated to the glucose
concentration. The
magnitude of the phase shift is independent of the amplitude of the emission.
101561 In other preferred embodiments, the system is excited by a pulse and
the
decay of the fluorescence is measured over time. The lifetime can be
determined using
Equation I described above, and glucose concentration can be correlated to the
lifetime
value.
(0157] In preferred embodiments, the glucose binding molecule with a donor
fluorophore and the glucose analog with an acceptor can be substantially
immobilized in the
-44-


CA 02686065 2009-11-02
WO 2008/141241 PCT/US2008/063330
hydrogel described above such that diffiision of the glucose binding molecule
and the glucose
analog out of the hydrogel is substantially reduced. In addition, the sensor
is configured to
provide excitation light at a wavelength absorbed by the donor fluorophore as
described
above. In some embodiments, the excitation light is provided as a short pulse
from a laser or
a light emitting diode (LED). In other embodiments, the excitation light is
frequency
modulated. In some embodiments, the frequency modulated excitation light is
provided by a
laser. In some embodiments the frequency modulated excitation light is
provided by a LED.
The sensor also has a detector that detects the amplitude of the emission over
time and/or the
phase shift of the emission and/or the amplitudes of the AC and DC portions of
the emission
and excitation light. The detector can be a photodetector or multiple
photodetectors. The
excitation and emission light can be transmitted tbroughout the sensor via
optical fibers.

101581 In some embodiments, the sensor can be introduced into a patient's
blood
vessel, such as a vein, artery or capillary, for measuring the intravascular
concentration of an
analyte in the patient"s blood. ln some embodiments, the chemistry used to
measure the
concentration of the analyte is based on a correlation of fluorescence
intensity of a
fluorophore to analyte concentration, as described above in more detail. ln
some
embodiments, the chemistry used to measure the concentration of the analyte is
based on a
correlation of fluorescence lifetime of a fluorophore to analyte
concentration, as described
above in more detail. ln some embodiments, the sensor is used to measure the
concentration
of glucose.
10159] While a number of preferred embodiments of the invention and variations
thereof have been described in detail, other modifications and methods of
using and medical
applications for the same will be apparent to those of skill in the art.
Accordingly, it should
be understood that various applications, modifications, and substitutions may
be made of
equivalents without departing from the spirit of the invention or the scope of
the claims.

-45-

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2008-05-09
(87) PCT Publication Date 2008-11-20
(85) National Entry 2009-11-02
Dead Application 2012-05-09

Abandonment History

Abandonment Date Reason Reinstatement Date
2011-05-09 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $400.00 2009-11-02
Maintenance Fee - Application - New Act 2 2010-05-10 $100.00 2009-11-02
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
GLUMETRICS, INC.
Past Owners on Record
MARKLE, DAVID R.
MARKLE, WILLIAM
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2010-01-06 1 32
Abstract 2009-11-02 2 55
Claims 2009-11-02 3 97
Drawings 2009-11-02 15 194
Description 2009-11-02 45 2,131
Representative Drawing 2009-11-02 1 5
PCT 2009-11-02 6 190
Assignment 2009-11-02 6 156